| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |